These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 18719906)

  • 1. Reduced striatal D2 receptor binding in myoclonus-dystonia.
    Beukers RJ; Booij J; Weisscher N; Zijlstra F; van Amelsvoort TA; Tijssen MA
    Eur J Nucl Med Mol Imaging; 2009 Feb; 36(2):269-74. PubMed ID: 18719906
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Alteration of striatal dopaminergic neurotransmission in a mouse model of DYT11 myoclonus-dystonia.
    Zhang L; Yokoi F; Parsons DS; Standaert DG; Li Y
    PLoS One; 2012; 7(3):e33669. PubMed ID: 22438980
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of [123I]IBZM pinhole SPECT for the detection of striatal dopamine D2 receptor availability in rats.
    Scherfler C; Scholz SW; Donnemiller E; Decristoforo C; Oberladstätter M; Stefanova N; Diederen E; Virgolini I; Poewe W; Wenning GK
    Neuroimage; 2005 Feb; 24(3):822-31. PubMed ID: 15652317
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 123I-IBZM SPECT: reconstruction methodology and results in parkinsonism and dystonia.
    Berding G; Gratz KF; Kolbe H; Meyer GJ; Dengler R; Knoop BO; Hundeshagen H
    Nuklearmedizin; 1994 Oct; 33(5):194-9. PubMed ID: 7997377
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Estimation of dopamine D2 receptor binding potential in the striatum with iodine-123-IBZM SPECT: technical and interobserver variability.
    Verhoeff NP; Kapucu O; Sokole-Busemann E; van Royen EA; Janssen AG
    J Nucl Med; 1993 Dec; 34(12):2076-84. PubMed ID: 8254390
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Single photon emission tomography (SPET) imaging of dopamine D2 receptors in the course of dopamine replacement therapy in patients with nocturnal myoclonus syndrome (NMS).
    Staedt J; Stoppe G; Kögler A; Riemann H; Hajak G; Munz DL; Emrich D; Rüther E
    J Neural Transm Gen Sect; 1995; 99(1-3):187-93. PubMed ID: 8579804
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Striatal dopamine D2 receptor binding and dopamine release during cue-elicited craving in recently abstinent opiate-dependent males.
    Zijlstra F; Booij J; van den Brink W; Franken IH
    Eur Neuropsychopharmacol; 2008 Apr; 18(4):262-70. PubMed ID: 18077142
    [TBL] [Abstract][Full Text] [Related]  

  • 8. IBZM SPECT imaging of striatal dopamine-2 receptors in psychotic patients treated with the novel antipsychotic substance quetiapine in comparison to clozapine and haloperidol.
    Küfferle B; Tauscher J; Asenbaum S; Vesely C; Podreka I; Brücke T; Kasper S
    Psychopharmacology (Berl); 1997 Oct; 133(4):323-8. PubMed ID: 9372530
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Varenicline increases in vivo striatal dopamine D2/3 receptor binding: an ultra-high-resolution pinhole [123I]IBZM SPECT study in rats.
    Crunelle CL; de Wit TC; de Bruin K; Ramakers RM; van der Have F; Beekman FJ; van den Brink W; Booij J
    Nucl Med Biol; 2012 Jul; 39(5):640-4. PubMed ID: 22261145
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Abnormal striatal and thalamic dopamine neurotransmission: Genotype-related features of dystonia.
    Carbon M; Niethammer M; Peng S; Raymond D; Dhawan V; Chaly T; Ma Y; Bressman S; Eidelberg D
    Neurology; 2009 Jun; 72(24):2097-103. PubMed ID: 19528516
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diagnostic value of asymmetric striatal D2 receptor upregulation in Parkinson's disease: an [123I]IBZM and [123I]FP-CIT SPECT study.
    Verstappen CC; Bloem BR; Haaxma CA; Oyen WJ; Horstink MW
    Eur J Nucl Med Mol Imaging; 2007 Apr; 34(4):502-7. PubMed ID: 17053905
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Striatal D2 receptor binding as a marker of prognosis and outcome in untreated first-episode psychosis.
    Corripio I; Pérez V; Catafau AM; Mena E; Carrió I; Alvarez E
    Neuroimage; 2006 Jan; 29(2):662-6. PubMed ID: 16112587
    [TBL] [Abstract][Full Text] [Related]  

  • 13. D2-dopamine receptor occupancy measured by IBZM-SPECT in relation to extrapyramidal side effects.
    Broich K; Grünwald F; Kasper S; Klemm E; Biersack HJ; Möller HJ
    Pharmacopsychiatry; 1998 Sep; 31(5):159-62. PubMed ID: 9832346
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Strength of cholinergic tone dictates the polarity of dopamine D2 receptor modulation of striatal cholinergic interneuron excitability in DYT1 dystonia.
    Scarduzio M; Zimmerman CN; Jaunarajs KL; Wang Q; Standaert DG; McMahon LL
    Exp Neurol; 2017 Sep; 295():162-175. PubMed ID: 28587876
    [TBL] [Abstract][Full Text] [Related]  

  • 15. No direct correlation between behaviorally active doses of the dopamine D2 agonist LY 171555 and displacement of [123I]IBZM as measured with SPECT in MPTP monkeys.
    Vermeulen RJ; Drukarch B; Verhoeff NP; Goosen C; Sahadat MC; Wolters EC; van Royen EA; Stoof JC
    Synapse; 1994 Jun; 17(2):115-24. PubMed ID: 7916490
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reduced striatal dopamine D2/3 receptor availability in Body Dysmorphic Disorder.
    Vulink NC; Planting RS; Figee M; Booij J; Denys D
    Eur Neuropsychopharmacol; 2016 Feb; 26(2):350-356. PubMed ID: 26711686
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vivo 123I IBZM SPECT imaging of striatal dopamine-2 receptor occupancy in schizophrenic patients treated with olanzapine in comparison to clozapine and haloperidol.
    Tauscher J; Küfferle B; Asenbaum S; Fischer P; Pezawas L; Barnas C; Tauscher-Wisniewski S; Brücke T; Kasper S
    Psychopharmacology (Berl); 1999 Jan; 141(2):175-81. PubMed ID: 9952042
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Iodine-123-IBZM dopamine D2 receptor and technetium-99m-HMPAO brain perfusion SPECT in the evaluation of patients with and subjects at risk for Huntington's disease.
    Ichise M; Toyama H; Fornazzari L; Ballinger JR; Kirsh JC
    J Nucl Med; 1993 Aug; 34(8):1274-81. PubMed ID: 8326384
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [123I]IBZM SPECT for imaging of striatal D2 dopamine receptors in 56 schizophrenic patients taking various neuroleptics.
    Klemm E; Grünwald F; Kasper S; Menzel C; Broich K; Danos P; Reichmann K; Krappel C; Rieker O; Briele B; Hotze AL; Möller HJ; Biersack HJ
    Am J Psychiatry; 1996 Feb; 153(2):183-90. PubMed ID: 8561197
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dopamine D2 receptor alteration in patients with periodic movements in sleep (nocturnal myoclonus).
    Staedt J; Stoppe G; Kögler A; Munz D; Riemann H; Emrich D; Rüther E
    J Neural Transm Gen Sect; 1993; 93(1):71-4. PubMed ID: 8103994
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.